CDNA logo

CDNA
Caredx Inc

3,218
Mkt Cap
$859.41M
Volume
621,994.00
52W High
$21.49
52W Low
$10.96
PE Ratio
-41.67
CDNA Fundamentals
Price
$16.43
Prev Close
$16.78
Open
$16.80
50D MA
$18.89
Beta
1.52
Avg. Volume
704,196.21
EPS (Annual)
-$0.4007
P/B
2.76
Rev/Employee
$496,477.12
$852.92
Loading...
Loading...
News
all
press releases
CareDx (NASDAQ:CDNA) Share Price Crosses Below Two Hundred Day Moving Average - Time to Sell?
CareDx (NASDAQ:CDNA) Shares Cross Below 200-Day Moving Average - Time to Sell...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
Fred Alger Management LLC Sells 304,736 Shares of CareDx, Inc. $CDNA
Fred Alger Management LLC trimmed its position in CareDx, Inc. (NASDAQ:CDNA - Free Report) by 24.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·14d ago
News Placeholder
Bamco Inc. NY Has $45.88 Million Stake in CareDx, Inc. $CDNA
Bamco Inc. NY grew its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 29.5% during the third quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·15d ago
News Placeholder
Braidwell LP Makes New Investment in CareDx, Inc. $CDNA
Braidwell LP purchased a new position in CareDx, Inc. (NASDAQ:CDNA - Free Report) in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange...
MarketBeat·16d ago
News Placeholder
CareDx, Inc. $CDNA Shares Purchased by ArrowMark Colorado Holdings LLC
ArrowMark Colorado Holdings LLC raised its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 34.4% during the third quarter, according to its most recent filing with the Securities and...
MarketBeat·16d ago
News Placeholder
Portolan Capital Management LLC Grows Stake in CareDx, Inc. $CDNA
Portolan Capital Management LLC raised its stake in shares of CareDx, Inc. (NASDAQ:CDNA - Free Report) by 48.2% in the third quarter, according to the company in its most recent 13F filing with the...
MarketBeat·17d ago
News Placeholder
CareDx Introduces VANTx AI Platform for Complex Transplant Datasets
CDNA launches VANTx, an AI-driven cloud platform that turns complex transplant datasets into insights to support clinical research and real-world evidence.
Zacks·19d ago
News Placeholder
CareDx Details Transplant+ Roadmap, AlloHeme Timeline, and 2026 Outlook at Raymond James Conference
CareDx (NASDAQ:CDNA) executives outlined the company's transplant-focused strategy, recent financial performance, and 2026 priorities during remarks at the Raymond James Institutional Investor...
MarketBeat·23d ago
News Placeholder
CareDx, Inc. (NASDAQ:CDNA) Given Consensus Rating of "Hold" by Analysts
CareDx, Inc. (NASDAQ:CDNA - Get Free Report) has received an average recommendation of "Hold" from the nine research firms that are covering the firm, MarketBeat.com reports. One investment analyst...
MarketBeat·24d ago
News Placeholder
CareDx Announces VANTx, an AIPowered Clinical Data & Analytics Platform Built on CareDxs Proprietary, Large-Scale, Longitudinal Solid Organ Transplant Datasets
CareDx, Inc. (Nasdaq: CDNA) The Transplant Company, a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, highvalue...
Business Wire·25d ago
<
1
2
...
>

Latest CDNA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.